Exane Derivatives’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $711K | Sell |
15,955
-4,425
| -22% | -$197K | 0.41% | 55 |
|
|
2022
Q1 | $1.15M | Sell |
20,380
-144
| -0.7% | -$8.15K | 0.32% | 73 |
|
|
2021
Q4 | $1.07M | Buy |
20,524
+17,162
| +510% | +$891K | 0.26% | 82 |
|
|
2021
Q3 | $201K | Sell |
3,362
-236
| -7% | -$14.1K | 0.05% | 380 |
|
|
2021
Q2 | $230K | Buy |
3,598
+2,262
| +169% | +$144K | 0.05% | 354 |
|
|
2021
Q1 | $87.1K | Sell |
1,336
-1,810
| -58% | -$118K | 0.02% | 429 |
|
|
2020
Q4 | $207K | Buy |
3,146
+1,747
| +125% | +$115K | 0.06% | 299 |
|
|
2020
Q3 | $72.3K | Hold |
1,399
| – | – | 0.02% | 327 |
|
|
2020
Q2 | $68.9K | Hold |
1,399
| – | – | 0.02% | 313 |
|
|
2020
Q1 | $71.3K | Sell |
1,399
-202
| -13% | -$10.3K | 0.02% | 306 |
|
|
2019
Q4 | $98.7K | Hold |
1,601
| – | – | 0.02% | 302 |
|
|
2019
Q3 | $80.6K | Hold |
1,601
| – | – | 0.01% | 321 |
|
|
2019
Q2 | $80.7K | Hold |
1,601
| – | – | 0.01% | 339 |
|
|
2019
Q1 | $74.4K | Buy |
1,601
+876
| +121% | +$40.7K | 0.01% | 304 |
|
|
2018
Q4 | $35.6K | Buy |
+725
| New | +$35.6K | 0.01% | 365 |
|